Vaccine

Article	Citations
“Fighting the pandemic!” Western Australian pharmacists’ perspectives on COVID-19 vaccines: A qualitative study	820
Syncope after live attenuated influenza vaccine: Reports to the Vaccine Adverse Event Reporting System (2003–2024)	216
Characterization of gH/gL/pUL128-131 pentameric complex, gH/gL/gO trimeric complex, gB and gM/gN glycoproteins in a human cytomegalovirus using automated capillary western blots	194
Knowledge, attitudes, and practices regarding seasonal influenza vaccination during pregnancy in Costa Rica: A mixed-methods study	192
Editorial Board/Aims and Scope	188
Increasing Ebola transmission behaviors 6 months post-vaccination: Comparing vaccinated and unvaccinated populations near 2018 Mbandaka Ebola outbreak in the Democratic Republic of Congo	188
Sublingual immunisation with GBS serotype III capsular polysaccharide-tetanus toxoid conjugate vaccine induces systemic and mucosal antibody responses which are opsonophagocytic and inhibit GBS coloni	169
Editorial Board/Aims and Scope	146
Managing multiplicity in clinical vaccine studies – A case study using a gatekeeping testing strategy	136
Epidemiological characteristics and serotype distribution of culture-confirmed pediatric pneumococcal pneumonia before and after PCV 10 introduction, a multicenter study in Bogota, Colombia, 2008–2019	134
UK healthcare professionals’ attitudes towards the introduction of varicella vaccine into the routine childhood vaccination schedule and their preferences for administration	129
Influenza vaccination in children with pulmonary disease during the COVID-19 pandemic	126
A place for neutrophils in the beneficial pathogen-agnostic effects of the BCG vaccine	125
Cost of illness due to pertussis in adults ≥50 years of age in the United Kingdom	121
Mass vaccination campaign during the 2016 influenza outbreak in Panama: Challenges and implications for COVID-19 vaccination efforts	112
Editorial Board/Aims and Scope	106
Prevalence of indications for adult hepatitis A vaccination among hepatitis A outbreak-associated cases, Three US States, 2016–2019	105
Retesting the hypothesis that early Diphtheria-Tetanus-Pertussis vaccination increases female mortality: An observational study within a randomised trial	95
The increasing age of respiratory syncytial virus-related hospitalisation during COVID-19 pandemic in Lyon was associated with reduced hospitalisation costs	95
Tackling the burden of mumps in the military: A report of the Defense Health Board	93
Determinants of immunization in polio super high-risk union councils of Pakistan	93
Humoral and cellular immune responses induced by serogroup W135 meningococcal conjugate and polysaccharide vaccines	92
Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study	88
TAK − 021, an inactivated Enterovirus 71 vaccine candidate, provides cross-protection against heterologous sub-genogroups in human scavenger receptor B2 transgenic mice	87
Long-term impact of rotavirus vaccination on all-cause and rotavirus-specific gastroenteritis and strain distribution in Central Kenya: An 11-year interrupted time-series analysis	87

Issues with infectious disease vaccine introduction into routine vaccination in Japan, and considerations for accelerating the process	86
COVID-19 vaccination communication: Effects of vaccine conspiracy beliefs and message framing among black and white participants	85
Pediatric otitis media in Japan: A nationwide longitudinal study of the pre- and post-pneumococcal conjugate vaccine eras born in 2001 and 2010	85
Expected endpoints from future chikungunya vaccine trial sites informed by serological data and modeling	82
Collateral damage from debunking mRNA vaccine misinformation	81
A randomized, blind, parallel controlled phase I clinical trial to evaluate the safety and preliminary immunogenicity of 23-valent pneumococcal polysaccharide vaccine in healthy people aged 2 years an	79
World Health Organization Expert Working Group: Recommendations for assessing morbidity associated with enteric pathogens	78
Safety surveillance of varicella vaccine using tree-temporal scan analysis	78
BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study	77
Monitoring COVID-19 vaccine use in Italian long term care centers: The GeroCovid VAX study	77
Reduced cell-mediated immune response in hyperglycemic NOD mice following influenza vaccination	75
Characteristics of reported mumps cases in the United States: 2018–2023	75
“Every interaction you have …should be an opportunity to discuss and offer influenza vaccination”. Health service perspectives on influenza vaccination promotion and delivery to Aboriginal families li	74
Knowledge, attitudes, and practices of healthcare providers regarding vaccinating children with cancer in Latin America and the Caribbean	74
Editorial Board/Aims and Scope	71
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys	71
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants	70
BCG for the prevention and treatment of allergic asthma	70
Editorial Board/Aims and Scope	70
Vaccination coverage in hematological patients undergoing chemotherapy: Should we move towards personalized vaccination?	70
Corrigendum to ‘Cross-protective efficacy of inactivated whole influenza vaccines against Korean Y280 and Y439 lineage H9N2 viruses in mice’ [Vaccine 39 (2021) 6213–6220]	68
Have vaccine hesitancy models oversimplified a complex problem to our detriment? The Adapted Royal Society of Canada vaccine uptake framework	68
Erratum to “Motivational interviewing and vaccine acceptance in children: The MOTIVE study” [Vaccine 40(12) (2022) 1846–1854]	68
The U.S. COVID-19 vaccination program: A look back and future directions	67
Corrigendum to “Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis” [Vaccine 40(41) (2022) 5971	66
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine	66
Erratum to “Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals” [Vaccine 41(37) (2023) 5469-5476]	66
Differences in school factors associated with adolescent HPV vaccination initiation and completion coverage in three Australian states	66
Quantitation and characterization of serotype 6A activation for pneumococcal conjugate vaccine by cryo-EM and SEC methods	65
COVID-19 and seasonal influenza: The potential 2021–22 “Twindemic”	64
Impact analysis of rotavirus vaccination in various geographic regions in Western Europe	64
Cost-effectiveness of anti-viral treatment for infants with RSV disease in the United Kingdom	63
Humoral immune response profile of a cattle herd vaccinated with 5- and 10-times Bakirköy strain sheep pox vaccine under field conditions	63
Moderate effectiveness of influenza vaccine in outpatient settings: A test-negative study in Beijing, China, 2023/24 season	62
Evaluation of dynamics of immune responses and protective efficacy in piglets immunized with an inactivated porcine reproductive and respiratory syndrome vaccine candidate	62
Cost-effectiveness of human papillomavirus vaccination in girls living in Latin American countries: A systematic review and meta-analysis	61
Effectiveness of the varicella vaccine in the real world, a matched case-control study	61
Vaccination during febrile illness, what do we know? A systematic-narrative hybrid review of the literature and international recommendations	59
Disproportionality analysis of reported drug adverse events to assess a potential safety signal for pentavalent vaccine in 2019 in El Salvador	58
Sustained antibody persistence for at least 15 years after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules: Third 5-year follow-up	58
Safety, efficacy, and DIVA feasibility on a novel live attenuated classical swine fever marker vaccine candidate	57
Letter to the editor: SARS-CoV-2 vaccination in children and adolescents with neurodevelopmental or psychiatric disorders	56
Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines	56
A universal live vaccine platform against multiple serotypes Streptococcus suis based on polyvalent antigen protein	56
RSV neutralization assays – Use in immune response assessment	55
Attitudes towards influenza and uptake of the flu vaccine: A survey of pharmacy staff working in English hospitals	55
Pneumonia hospitalization after introduction of pneumococcal conjugate vaccine in Japan: Descriptive study using a nationwide claims database	55
Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental chal	54
A decade of rotavirus vaccination in the World Health Organization African Region: An in-depth analysis of vaccine coverage from 2012 to 2023	54
Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria	52

U.S. public support and opposition to vaccination mandates in K-12 education in light of the COVID-19 pandemic	52
The methodological quality of economic evaluations of measles outbreaks: A systematic review of cost-of-illness studies	51
Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic	51
Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the fi	50
Participant-reported neurological events following immunization in the Canadian National Vaccine Safety Network-COVID-19 vaccine (CANVAS-COVID) study	50
Pre-implementation evaluation for an HPV vaccine provider communication intervention among primary care clinics	50
COVID-19 and seasonal flu vaccination hesitancy: Links to personality and general intelligence in a large, UK cohort	49
Changes in childhood vaccination during the coronavirus disease 2019 pandemic in Japan	47
Supply, then demand? Health expenditure, political leanings, cost obstacles to care, and vaccine hesitancy predict state-level COVID-19 vaccination rates	47
Effectiveness of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children <2 years old: A prospective population-based study in rural Bangladesh	46
Parental socioeconomic and psychological determinants of the 2009 pandemic influenza A(H1N1) vaccine uptake in children	46
Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink	46
Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVΔG-ZEBOV-GP)	46
Influences of sociodemographic characteristics and parental HPV vaccination hesitancy on HPV vaccination coverage in five US states	46
COVID-19 vaccine hesitancy among persons living in homeless shelters in France	45
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisation	45
Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States	45
Cross-protective efficacy and safety of an adenovirus-based universal influenza vaccine expressing nucleoprotein, hemagglutinin, and the ectodomain of matrix protein 2	45
Uptake of COVID-19 vaccines among healthcare workers and the effect of nudging interventions: A mixed methods study	44
Using the precaution adoption process model to understand decision-making about the COVID-19 booster vaccine in England	44
Purification of recombinant vesicular stomatitis virus-based HIV vaccine candidate	44
Stability studies for the identification of critical process parameters for a pharmaceutical production of the Orf virus	44
Dynamics of global emergency vaccine stockpiles: A systems analysis and application to cholera	44
Compliance, procrastination and refusal: American COVID-19 vaccination trust and value orientation	44
100 years of the Bacillus Calmette-Guérin vaccine	43
Healthcare professional and professional stakeholders’ perspectives on vaccine mandates in Switzerland: A mixed-methods study	43
General vaccination willingness and current vaccination status in relation to clinical and psychological variables in patients with multiple sclerosis	43
Behaviors, perceptions, and impact of the COVID-19 pandemic and vaccination on oncology patients in New Mexico with substantial representation of racial minorities and rural residents	43
Immunogenicity and protective efficacy of a trimeric full-length S protein subunit vaccine for porcine epidemic diarrhea virus	43
Integrating the person-centered approach with the study of vaccine hesitancy: Applying latent profile analysis to identify vaccine hesitancy subpopulations and assess their relations with correlates a	43
Vaccine efficacy induced by 2020-2021 seasonal influenza-derived H3N1 virus-like particles co-expressing M2e5x or N2	42
Corrigendum to ‘A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older’ Vac	42
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysacchar	42
Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada	42
Use of an adapted participatory learning and action cycle to increase knowledge and uptake of child vaccination in internally displaced persons camps (IVACS): A cluster-randomised controlled trial	42
The projected cost-effectiveness and budget impact of HPV vaccine introduction in Ghana	41
Evaluating concurrency and gaps between self-report and vaccine card data for COVID-19 vaccination	41
Relative effectiveness of homologous NVX-CoV2373 and BNT162b2 COVID-19 vaccinations in South Korea	41
Immunogenicity and safety of routine 13-valent pneumococcal conjugate vaccination outside recommended age range in patients with hematological malignancies and solid tumors	41
An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-con	41
Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations	41
COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization	41
Vaccine financing in the Middle East and Africa: An overview from 2010 to 2019	41
Social and demographic patterns of influenza vaccination coverage in Norway, influenza seasons 2014/15 to 2020/21	41
A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults	41
Fear, mistrust, and vaccine hesitancy: Narratives of the dengue vaccine controversy in the Philippines	40
Liposomal co-encapsulation of a novel gemini lipopeptide and a CpG-ODN induces a strong Th1 response with the co-activation of a Th2/Th17 profile and high antibody levels	40
The impact of Facebook’s vaccine misinformation policy on user endorsements of vaccine content: An interrupted time series analysis	40
HPV vaccination acceptance and perceptions related to fertility and population control in the Gambia: An anthropological analysis	40
Why did Brazil fail to vaccinate children against COVID-19 during the pandemic? An assessment of attitudinal and behavioral determinants	40
Influenza vaccination uptake among Canadian adults before and during the COVID-19 pandemic: An analysis of the Canadian Longitudinal study on Aging (CLSA)	40
WITHDRAWN: Author response to a Letter to the Editor on “Introductory paper: High dose influenza vaccine”	39
Exposure to objective/sensationalist information moderates associations between psychological factors and COVID-19 anti-vaccination attitudes: An experimental study	39
Editorial Board/Aims and Scope	38
Factors associated with vaccination intention and uptake over time in a sample of older Australians	38
A three antigen hepatitis B vaccine induces T cells to Pres1 and Pres2 which correlate with anti HBs antibody titers: An investigation into the immunological mechanisms contributing to high anti-HBs t	38
Editorial Board	38
Editorial Board/Aims and Scope	38
Low neutralization of SARS-CoV-2 Omicron BA.5.2.48 and XBB.1 sub-variants in response to breakthrough infection by booster	37
Editorial Board/Aims and Scope	37
Are intelligent people more likely to get vaccinated? The association between COVID-19 vaccine adherence and cognitive profiles	37
Editorial Board/Aims and Scope	37
Phenotypic and genetic characterization of a next generation live-attenuated yellow fever vaccine candidate	36
Evaluation of anti-Pertussis antibody levels in Iranian infants and children: Is it time to include booster acellular Pertussis Vaccines in the immunization schedule?	36
Genetic and epidemiological description of an outbreak of circulating vaccine-derived polio-virus type 2 (cVDPV2) in Angola, 2019–2020	36
Need for a contingency dimension when planning vaccine development in a pandemic environment	36
Weighing the risks and benefits: Parental perspectives on COVID-19 vaccines for 5- to 11-year-old children	36
Epigenetic changes related to glucose metabolism in type 1 diabetes after BCG vaccinations: A vital role for KDM2B	36
Adaptive immune response to a wild boar-derived recombinant hepatitis e virus capsid protein challenge in pigs	36
Editorial Board/Aims and Scope	36
COVID-19 vaccine decision-making among Black women: A qualitative study	36
Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workers	36
Editorial Board/Aims and Scope	36
Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9–45 years of age: A phase 3 open-label study	35
Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates	35
Vaccination patterns and up-to-date status of children 19–35 months, 2011–2021	35
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022	35
The age-specific impact of COVID-19 vaccination on medical expenditures and hospitalization duration after breakthrough infection: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) S	35
Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine	34
Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workers	34

County-level correlates of completed HPV vaccination in Indiana	34
Rotavirus vaccine-derived cases in Belgium: Evidence for reversion of attenuating mutations and alternative causes of gastroenteritis	34
Utility of edible plant-derived exosome-like nanovesicles as a novel delivery platform for vaccine antigen delivery	34
Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008–2018)	34
How manufacturing won or lost the COVID-19 vaccine race	33
Vaccination, human mobility, and COVID-19 health outcomes: Empirical comparison before and during the outbreak of SARS‐Cov-2 B.1.1.529 (Omicron) variant	33
Staff and caregivers' perceptions of digital storytelling to increase influenza vaccine confidence in an urban safety-net healthcare system	33
Mapping the distribution of zero-dose children to assess the performance of vaccine delivery strategies and their relationships with measles incidence in Nigeria	33
Single immunization of non-adjuvanted recombinant TTFC-mi3 nanoparticle vaccine elicited a rapid and potent protective immunity against tetanus	33
Determinants of COVID-19 vaccine hesitancy and resistance in Russia	33
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vacc	32
Seroprotection against tetanus in the Italian general population	32
Nanoparticles displaying fHbp elicit an enhanced antibody response against meningococcal B isolates compared to low valency fHbp antigens	32
Pertussis in Asia: Recent country-specific data and recommendations	32
Pertussis burden and acellular pertussis vaccine effectiveness in high risk children	32
Corrigendum to, “Attitudes and beliefs of healthcare providers toward vaccination in the United States: A cross-sectional online survey” [Vaccine (2024) Dec 2 42(26) 126437]	32
Strengthening immunization programs through innovative sub-national public-private partnerships in selected provinces in the Democratic Republic of the Congo	32
UAE efforts in promoting COVID-19 vaccination and building vaccine confidence	32
A novel high throughput plate-based method for 2-PE quantification in novel multidose vaccines (R21 malaria, Covishield and Covovax) and combination vaccines (Hexavalent)	31
Association of dual COVID-19 and seasonal influenza vaccination with COVID-19 infection and disease severity	31
Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design	31
In ovo administration of retinoic acid enhances cell-mediated immune responses against an inactivated H9N2 avian influenza virus vaccine	31
Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort study	31
Immunogenicity and safety of a SARS-CoV-2 mRNA vaccine (SYS6006) in healthy Chinese participants: A randomized, observer-blinded, placebo-controlled phase 2 clinical trial	31
Crowdfunding narratives and the valuation of vaccines for COVID-19	31
Mathematical modelling of the 100-day target for vaccine availability after the detection of a novel pathogen: A case study in Indonesia	30
Coverage of influenza, pneumococcal and zoster vaccination and determinants of influenza and pneumococcal vaccination among adults with cardiovascular diseases in community	30
Antibody kinetics between birth and three months of life in healthy infants with natural exposure to Group B streptococcus: A UK cohort study	30
Immunogenicity and immune persistence in 4-year-old children completing four doses of Sabin strain or wild strain inactivated poliovirus vaccine: A phase IV, open-labeled, parallel-controlled observat	30
The impact of COVID-19 childhood and adolescent vaccination on mortality in Argentina	30
COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic	30
Safety and 6-month immune persistence of inactivated poliovirus vaccine (Sabin strains) simultaneously administrated with other vaccines for primary and booster immunization in Jiangxi Province, China	30
Covid-19 and influenza vaccine effectiveness against associated hospital admission and death among individuals over 65 years in Norway: A population-based cohort study, 3 October 2022 to 20 June 2023	30
Corrigendum to “Impact of a quadrivalent inactivated influenza vaccine on influenza-associated complications and health care use in children aged 6 to 35 months: Analysis of data from a phase III tria	30
Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development	29
Editorial Board	29
Aggregating human judgment probabilistic predictions of the safety, efficacy, and timing of a COVID-19 vaccine	29
Antitumoral effectiveness and safety of intravenous versus subcutaneous administration of immunomodulatory peptide GK-1 in a murine breast cancer model	29
Persistence of immunity in children aged 2 months and 7 months – 5 years old after primary immunization with 13-valent pneumococcal conjugate vaccine	29
“EvoVax” – A rationally designed inactivated Salmonella Typhimurium vaccine induces strong and long-lasting immune responses in pigs	29
Increasing vaccination coverage among healthcare workers: Active call and mandatory laws. Data from a large general hospital in Southern Italy	29
Implementation strategies for the first licensed dengue vaccine: A meeting report	29
Henoch-Schönlein purpura presenting post COVID-19 vaccination	29
Efficiency of indirect protection of COVID-19 vaccination and interactions between indirect and direct protection on household transmission	29
Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health	28
“COVID is a huge jigsaw puzzle that I am trying to make sense of myself”: Exploring the perceptions towards the COVID-19 vaccine communication strategy in Australia amongst unvaccinated Australian adu	28
An intranasal nanoparticle vaccine elicits protective immunity against Mycobacterium tuberculosis	28
Evaluation of bird-adapted self-amplifying mRNA vaccine formulations in chickens	28
Frequency and temporal evolution of COVID-19 vaccination rate among oncological patients undergoing 18F-FDG-PET	28
Harmonized case definitions for endpoints in vaccine efficacy trials are needed	28
Cost-utility analysis of the use of the 20-valent anti-pneumococcal vaccine (PCV20) in adults older than 60 years in Spain	28
High prevalence of human papillomavirus (HPV) in unvaccinated adolescent girls in South Africa, particularly those living with HIV	28
Concordance of self-reported varicella history and serology among adolescent and adult refugee patients at a primary care clinic in Toronto, Canada	28
Associations between family planning, healthcare access, and female education and vaccination among under-immunized children	28
Documenting human papillomavirus vaccine refusal among adolescents in electronic health records: A mixed methods study	28
Quadrivalent neuraminidase RNA particle vaccine protects pigs against homologous and heterologous strains of swine influenza virus infection	28
Distinct features of SARS-CoV-2 humoral immunity against Omicron breakthrough infection	28
Views on COVID-19 vaccination of young children in Ireland, results from a cross-sectional survey of parents	28
Could live attenuated vaccines better control COVID-19?	28
Papillomavirus vaccination and Guillain-Barre Syndrome among girls: A cohort study in Spain	27
The impact of an educational forum intervention on East African mothers’ HPV vaccine-related knowledge, attitudes, and intentions to vaccinate their adolescent children	27
Donor Unrestricted T Cells: Linking innate and adaptive immunity	27
Evaluation of the humoral response to the third dose of SARS-COV-2 vaccines in liver transplant recipients	27
Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan	27
Operational research for the safe and effective design of COVID-19 mass vaccination centres	27
Comparing performance of year-round and campaign-mode influenza vaccination strategies among children aged 6–23 months in Kenya: 2019–2021	27
Intent to receive flu vaccine and influenza vaccination coverage among health professionals during 2019, 2020 and 2021 campaigns in Côte d’Ivoire	27
Mumps virus neurovirulence assessment-impact of viral doses, animal sex and age on results dispersion	27
Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan	27
Changes in depressive symptoms and antibody production following influenza vaccination in adolescents and adults	27
Immunogenicity and lot-to-lot consistency of booster shot with Sabin inactivated poliomyelitis vaccine in Chinese children aged 18–24 Months: A phase Ⅳ clinical trial	27
Meeting report: WHO consultation on malaria vaccine development, Geneva, 15–16 July 2019	27
Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization R	27
Impact of national introduction of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Bangladesh: Case-control and time-trend studies	26
Prevalence of poliovirus neutralizing antibodies in Italian population: A systematic review and meta-analysis	26
HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study	26
Construction of a Lactobacillus plantarum-based claudin-3 targeting delivery system for the development of vaccines against Eimeria tenella	26
Maternal transfer of neutralizing antibodies to B. burgdorferi OspA after oral vaccination of the rodent reservoir	26
How has post-implementation surveillance of high-coverage vaccination with HPV16/18-AS04 vaccine in England added to evidence about its cross-protective effects?	26
The influenza vaccines roadmap – A better future through improved influenza vaccines	26
Use of protective antigen of Bacillus anthracis as a model recombinant antigen to evaluate toll-like receptors 2, 3, 4, 7 and 9 agonists in mice using established functional antibody assays, antigen-s	26
Comparison of performance of varicella vaccines via infectious disease modeling	26
Evaluation of three hemagglutinin-based vaccines for the experimental control of a panzootic clade 2.3.4.4b A(H5N8) high pathogenicity avian influenza virus in mule ducks	26
Applying the COM-B behaviour model to understand factors which impact school immunisation nurses’ attitudes towards designing and delivering a HPV educational intervention in post-primary schools for	26
Impact of the surge of COVID-19 Omicron outbreak on the intention of seasonal influenza vaccination in Hong Kong: A cross-sectional study	26
A broad and potent IgM antibody against tetra-EV-As induced by EVA71 and CVA16 co-immunization	26
Public health impact and cost-effectiveness of implementing a ‘pre-vaccination screening' strategy with the dengue vaccine in Puerto Rico	26
The impact of a vaccine mandate and the COVID-19 pandemic on influenza vaccination uptake in Western Australian health care students	26
Occupation, Worker Vulnerability, and COVID-19 Vaccination Uptake: Analysis of the Virus Watch prospective cohort study	26
Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022	25
National introduction of HPV vaccination in Senegal—Successes, challenges, and lessons learned	25
COVID-19 vaccine preferences in India	25
Impact of electronic immunization registries and electronic logistics management information systems in four low-and middle-income countries: Guinea, Honduras, Rwanda, and Tanzania	25
Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research	25
Tanzania’s human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019	25